Acute, Multiple-Dose Dermal and Genetic Toxicity of Nu-3: A Novel Antimicrobial Agent

Figure 4

Clinical observations after repeated dermal doses of Nu-3 for 28 days. (a) Body weight; (b) water uptake; (c) food uptake.

(a)

(b)

(c)